A study of parkinsonism in multiple system atrophy: clinical and MRI correlation
Corresponding Author
M. Wakai
Departments of Neurology Nagoya University School of Medicine
M. Wakai, Department of Neurology, Nagoya University School of Medicine, 65 Tsurumai-cno, Shouwaku, Nagoya 466, JapanSearch for more papers by this authorA. Kume
Departments of Neurology Nagoya University School of Medicine
Search for more papers by this authorA. Takahashi
Departments of Neurology Nagoya University School of Medicine
Search for more papers by this authorY. Hashizume
Institute for Medical Science of Aging, Aichi Medical University, Japan
Search for more papers by this authorCorresponding Author
M. Wakai
Departments of Neurology Nagoya University School of Medicine
M. Wakai, Department of Neurology, Nagoya University School of Medicine, 65 Tsurumai-cno, Shouwaku, Nagoya 466, JapanSearch for more papers by this authorA. Kume
Departments of Neurology Nagoya University School of Medicine
Search for more papers by this authorA. Takahashi
Departments of Neurology Nagoya University School of Medicine
Search for more papers by this authorY. Hashizume
Institute for Medical Science of Aging, Aichi Medical University, Japan
Search for more papers by this authorAbstract
We investigated clinical and MRI correlation in 18 patients with clinically-diagnosed multiple system atrophy (MSA) and 16 age-matched controls, using 1.5 T magnetic resonance imaging (MRI). We evaluated the severity of parkinsonism in each MSA patient. In assessing the MRI findings, we examined three parameters quantitatively: width of the pars compacta of the substantia nigra (SNc); putaminal hypointensity on T2-weighted images; and putaminal atrophy. As in previous studies, SNc width was narrowed and the putaminal signal intensity was decreased in patients with MSA compared with controls. The clinical severity of parkinsonism did not correlate significantly with the SNc width or the score of putaminal hypointensity in MSA. However, not only did putaminal atrophy occur, but correlated well with the severity of parkinsonism in MSA. A significant correlation could not be established between narrowing of SNc and shrinkage of the putamen. These findings suggest that putaminal atrophy is associated with the clinical manifestations of parkinsonism and do not support the hypothesis that transsynaptic degeneration occurs in MSA.
References
- 1 Adams RD, van Bogaert L., van der Ecken D.. Dégénérescences nigro-striées et cerebello-nigro-striées (Unicité clinique et variabilité pathologique des dégénérescences préséniles à forme de rigidité extrapyramidale). Psychiatr Neurol Basel 1961: 142: 219–259.
- 2 Dejerine J., Thomas A.. L'atrophie olivo-ponto-cérébelleuse. Nouv Iconogr Salpet 1900: 13: 330–370.
- 3 Shy GM, Drager GA. A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study. Arch Neurol 1960: 2: 511–527.
- 4 Adams RD, van Bogaert L., van der Ecken H.. Striaionigral degeneration. J Neuropathol Exp Neurol 1964: 23: 584–608.
- 5 Johnson RH, Lee G de J., Oppenheimer DR, Spalding JMK. Autonomic failure with orthostatic hypotension due to intermediolateral column degeneration: a report of two cases with autopsies. Q J Med 1966: 35: 276–292.
- 6 Takahashi A., Takagi S., Yamamoto K., Yamada T., Andoh K.. Shy-Drager syndrome Its correlation with olivoponto-cerebellar atrophy. Clin Neurol (Tokyo) 1969: 9: 121–129.
- 7 Oppenheimer DR. Multiple system atrophy and the Shy-Drager syndrome. In: Spinocerebellar Degeneration. Baltimore : University Park Press, 1980: 165–170.
- 8 Oppenheimer DR. Lateral horn cells in progressive autonomic failure. J Neurol Sci 1980: 46: 393–404.
- 9 Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969: 32: 28–34.
- 10 Bannister R., Oppenheimer DR. Degenerative diseases of the nervous system associated with autonomic failure. Brain 1972: 95: 457–474.
- 11 Spokes EGS, Bannister R., Oppenheimer DR. Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases. J Neurol Sci 1979: 43: 59–82.
- 12 Takei Y., Mirra SS. Striatonigral degeneration: a form of multiple system atrophy with clinical parkinsonism. In: Progress in neuropathology, Vol. 2. New York : Grune & Stratton, 1973: 217–251.
- 13 Gosset A., Pellissier JF, Delpuech F., Khalil R.. Dégénérescence striato-nigrique associée à une atrophie olivoponto-cérébelleuse: étude anatomo-clinique de trois cas. Discussion nosologique. Rev Neurol (Paris) 1983: 139: 125–139.
- 14 Riku S., Hashizume Y.. A clinico-pathological study on multiple system atrophy with special reference to its Striatonigral lesions and motor neuron involvements. Clin Neurol (Tokyo) 1984: 24: 552–561.
- 15 Kume A., Takahashi A., Hashizume Y., Asai J.. A histochemical and comparative study on Purkinje cells loss and olivary nucleus cell loss in multiple system atrophy. J Neurol Sci 1991: 101: 178–186.
- 16 Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989: 94: 79–100.
- 17 Drayer BP, Olanow W., Burger P., Johnson GA, Herfkens R., Riederer S.. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron 1. Radiology 1986: 159: 493–498.
- 18 Pastakia B., Polinsky R., Di Chiro G., Simmons JT, Brown R., Wener L.. Multiple system atrophy (Shy-Drager syndrome): MR imaging. Radiology 1986: 159: 499–502.
- 19 Brown R., Polinsky R., Di Chiro G., Pastakia B., Wener L., Simmons JT. MRI in autonomic failure. J Neurol Neurosurg Psychiatry 1987: 50: 913–914.
- 20 Mukai E., Making N., Fujishiro K.. Magnetic resonance imaging of Parkinsonism. Clin Neurol (Tokyo) 1989: 29: 720–725.
- 21 Savoiardo M., Strada L., Girqtti F. et al. MR imaging in progressive supranuclear palsy and Shy-Drager syndrome. J Comput Assist Tomogr 1989: 13: 555–560.
- 22 Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 1989: 39: 1524–1526.
- 23 Savoiardo M., Strada L., Girotti F. et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990: 174: 693–696.
- 24 Kume A., Shiratori M., Takahashi A. et al. Hemiparkinsonism in multiple system atrophy: a PET and MRI study. J Neurol Sci 1992: 110: 37–45.
- 25 Aotsuka A., Shintoh H., Hirayama K., Ikehira H., Hashimoto T.. Magnetic resonance imaging in multiple system atrophy. Clin Neurol (Tokyo) 1992: 32: 815–821.
- 26 Duguid JR, De La Paz R., DeGroot J.. Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986: 20: 744–747.
- 27 Singer HS, Reiss AL, Brown JE et al. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 1993: 43: 950–956.
- 28 Kato T., Kume A., Ito K., Tadokoro M., Takahashi A., Sakuma S.. Asymmetrical FDG-PET and MRI findings of striatonigral system in multiple system atrophy with hemiparkinsonism. Radiat Med (Tokyo) 1992: 10: 87–93 (in English).
- 29 Drayer B., Burger P., Darwin R., Riederer S., Herfkens R., Johnson GA. Magnetic resonance imaging of brain iron. Am J Neuroradiol 1986: 7: 373–380.
- 30 Rutledge JN, Hial SK, Silver AJ, Defendini R., Fahn S.. Study of movement disorders and brain iron by MR. Am J Neuroradiol 1987: 8: 397–411.
- 31 O'Brien C., Sung JH, McGeachie RE, Lee MC. Striatonigral degeneration: clinical, MRI, and pathologic correlation. Neurology 1990: 40: 710–711.
- 32 Fearnley JM, Lees AJ. Striatonigral degeneration: a clinicopathological study. Brain 1990: 113: 1823–1824.
- 33 Gibb WRG. Neuropathology of the substantia nigra. Eur Neurol 1991: 31 (suppl 1): 48–59.
- 34 Borit A., Rubinstein LJ, Urich H.. The striatonigral degenerations. Putaminal pigments and nosology. Brain 1975: 98: 101–112.
- 35 Churchyard A., Donnan GA, Hughes A. et al. Dopa resistance in multiple system atrophy: loss of postsynaptic D2 receptors. Ann Neurol 1993: 34: 219–226.
